Back

Response to up-titration of therapies in patients with new-onset heart failure with and without atrial fibrillation

12 May 2024 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - pharmacotherapy 1 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Ms Arietje Johanna Lena Zandijk

University Medical Centre Groningen, Groningen (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
COR-1167, a new long-acting CRF2 receptor agonist, decreases congestion by improving cardiorenal function in a sheep model of worsening heart failure (WHF)
Doctor P. Janiak (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: the PARAGLIDE-HF Trial
Doctor A. Peters (Durham, US)
Abstract Slides Video
Presentation thumbnail
The impact of intrarenal venous doppler-guided diuretic management on hospital stay
Doctor M. Passos (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Mild-to-moderate chronic kidney disease predicts underutilisation of guideline-directed medical therapies in patients with acute heart failure
Associate Professor M. Polovina (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Heart failure early post discharge appointment: a 2.5-year single-center experience
Doctor M. Passos (Amadora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - pharmacotherapy 1

The Event

Event poster

Heart Failure 2024

12 May 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Optimal medical therapy of AF in HFpEF and HFrEF
20 May 2023
thumbnail
Congress Presentation
Impact of af on sacubitril/valsartan dosing, persistance of treatment and associated outcomes in heart failure patients with reduced ejection fraction
12 May 2024
thumbnail
Congress Session
Treatment of HFrEF
1 September 2025
thumbnail
Congress Presentation
Broadening the scope of cardiac resynchronization therapy in atrial fibrillation patients
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources